Timing
Purchase and sale flow
PurchasesSales
Stock, pipeline and biotech catalyst intelligence
Reported ownership activity
Activity signal
Reported sales exceed purchases by $8.7MOption exercises, awards, and grants are separated from open-market direction.Timing
Composition
Concentration
Company profile
Sensei Biotherapeutics is a biotechnology company in the healthcare sector.
Company profile compiled from available company records. Catalyst dates can change and should be confirmed against the linked primary source.
Page updated Aug 23, 2026 · Yahoo quotes cached for one minute; reference data may be used when a live field is unavailable.
| Insider trading | Relationship | Date | Transaction | Cost | Shares | Value | Shares total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Cambrian Biopharma Inc | 10% Owner | Jul 22 '26 | Proposed Sale | $27.99 | 130,142 | $3,642,675 | — | Aug 11 12:52 PM |
| Stephenson Brian C | Chief Financial Officer | Jun 30 '26 | Buy | $24.25 | 7,803 | $189,240 | 41,688 | Jul 01 08:09 PM |
| Stephenson Brian C | Chief Financial Officer | Jul 01 '26 | Buy | $23.50 | 5,000 | $117,492 | 46,688 | Jul 01 08:09 PM |
Transactions may include sales, purchases, grants, and option exercises. Directional charts count only purchases and sales; follow the Form 4 link to verify the original SEC filing.